(NASDAQ: ACOG) Alpha Cognition's forecast annual revenue growth rate of 93.77% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.28%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Alpha Cognition's revenue in 2025 is $7,427,199.On average, 4 Wall Street analysts forecast ACOG's revenue for 2025 to be $235,314,792, with the lowest ACOG revenue forecast at $213,550,945, and the highest ACOG revenue forecast at $255,687,143. On average, 4 Wall Street analysts forecast ACOG's revenue for 2026 to be $573,469,735, with the lowest ACOG revenue forecast at $507,112,834, and the highest ACOG revenue forecast at $637,348,037.
In 2027, ACOG is forecast to generate $1,245,170,296 in revenue, with the lowest revenue forecast at $1,196,337,530 and the highest revenue forecast at $1,281,783,999.